These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 21432601)

  • 21. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Attention-deficit/hyperactivity disorder. Clinical and treatment aspects].
    Diaconu G; Grigore I; Burlea M
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):656-62. PubMed ID: 20191811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing computational models of dopamine and noradrenaline dysfunction in attention deficit/hyperactivity disorder.
    Frank MJ; Santamaria A; O'Reilly RC; Willcutt E
    Neuropsychopharmacology; 2007 Jul; 32(7):1583-99. PubMed ID: 17164816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of attention-deficit/hyperactivity disorder: overview of the evidence.
    Brown RT; Amler RW; Freeman WS; Perrin JM; Stein MT; Feldman HM; Pierce K; Wolraich ML; ;
    Pediatrics; 2005 Jun; 115(6):e749-57. PubMed ID: 15930203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses.
    Genro JP; Kieling C; Rohde LA; Hutz MH
    Expert Rev Neurother; 2010 Apr; 10(4):587-601. PubMed ID: 20367210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 27. National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder.
    Visser SN; Lesesne CA; Perou R
    Pediatrics; 2007 Feb; 119 Suppl 1():S99-106. PubMed ID: 17272592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of NSS in ADHD.
    Pasini A; D'agati E
    World J Biol Psychiatry; 2009; 10(4 Pt 2):495-502. PubMed ID: 19337883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attention deficit hyperactivity disorder. Epidemiologic, pathophysiologic, diagnostic and treatment perspectives.
    Al-Ghamdy YS; Qureshi NA
    Saudi Med J; 2001 Aug; 22(8):666-73. PubMed ID: 11573110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
    Ruocco LA; Carnevale UA; Treno C; Sadile AG; Melisi D; Arra C; Ibba M; Schirru C; Carboni E
    Behav Brain Res; 2010 Jun; 210(1):99-106. PubMed ID: 20156489
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder.
    Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT
    Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced salivary cortisol in children with comorbid Attention deficit hyperactivity disorder and oppositional defiant disorder.
    Kariyawasam SH; Zaw F; Handley SL
    Neuro Endocrinol Lett; 2002 Feb; 23(1):45-8. PubMed ID: 11880861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of the catechol-O-methyltransferase polymorphism with methylphenidate response in a classroom setting in children with attention-deficit hyperactivity disorder.
    Cheon KA; Jun JY; Cho DY
    Int Clin Psychopharmacol; 2008 Sep; 23(5):291-8. PubMed ID: 18703939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of methylphenidate on Internet video game play in children with attention-deficit/hyperactivity disorder.
    Han DH; Lee YS; Na C; Ahn JY; Chung US; Daniels MA; Haws CA; Renshaw PF
    Compr Psychiatry; 2009; 50(3):251-6. PubMed ID: 19374970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic treatment of attention deficit hyperactivity disorder.
    Greenhill LL
    Psychiatr Clin North Am; 1992 Mar; 15(1):1-27. PubMed ID: 1347936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulants and growth in children with attention-deficit/hyperactivity disorder.
    Negrao BL; Viljoen M
    Med Hypotheses; 2011 Jul; 77(1):21-8. PubMed ID: 21444155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Working toward a neurobiological account of ADHD: commentary on Gail Tripp and Jeff Wickens, dopamine transfer deficit.
    Williams J
    J Child Psychol Psychiatry; 2008 Jul; 49(7):705-11; discussion 711. PubMed ID: 18598242
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of executive function in ADHD.
    Swanson JM
    J Clin Psychiatry; 2003; 64 Suppl 14():35-9. PubMed ID: 14658934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine vs noradrenaline: inverted-U effects and ADHD theories.
    Levy F
    Aust N Z J Psychiatry; 2009 Feb; 43(2):101-8. PubMed ID: 19153917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attention deficit/hyperactivity disorder--from brain dysfunctions to behaviour.
    Sagvolden T; Sergeant JA
    Behav Brain Res; 1998 Jul; 94(1):1-10. PubMed ID: 9708834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.